Triazole compounds as T-type calcium channel blockers
申请人:IDORSIA PHARMACEUTICALS LTD
公开号:US10246426B2
公开(公告)日:2019-04-02
The invention relates to compounds of formula (I)
wherein
X, Y, R1, R2, (R4)n, and (R5)m are as defined in the description, and to pharmaceutically acceptable salts of such compounds. These compounds are useful as calcium T-channel blockers.
本发明涉及式 (I) 的化合物
其中
X、Y、R1、R2、(R4)n 和 (R5)m 如描述中所定义,以及此类化合物的药学上可接受的盐类。这些化合物可用作钙 T 通道阻滞剂。
TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS
申请人:Idorsia Pharmaceuticals Ltd
公开号:EP3194374B1
公开(公告)日:2018-08-01
[EN] TRIAZOLE COMPOUNDS AS T-TYPE CALCIUM CHANNEL BLOCKERS<br/>[FR] COMPOSÉS TRIAZOLE UTILISÉS COMME BLOQUEURS DES CANAUX CALCIQUES DE TYPE T
申请人:ACTELION PHARMACEUTICALS LTD
公开号:WO2016041892A1
公开(公告)日:2016-03-24
The invention relates to compounds of formula (I) wherein X, Y, R1, R2, (R4)n, and (R5)m are as defined in the description, and to pharmaceutically acceptable salts of such compounds. These compounds are useful as calcium T-channel blockers.